Kamada Ltd. (NASDAQ:KMDA) management will conduct a conference call for 11th November 2020 at 8:30 AM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.kamada.com
Earnings Expectation
Kamada Ltd. is reporting third quarter financial results on Wednesday 11th November 2020, before market open.
According to analysts surveyed by Thomson Reuters, KMDA is expected to report 3Q20 income of $ 0.06 per share from revenue of $ 33.19 million.
For the full year, analysts anticipate top line of $ 134.75 million, while looking forward to income of $ 0.36 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 132.00 million ~ $ 137.00 million
Click Here For More Historical Outlooks Of Kamada Ltd.
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates through two segments, Proprietary Products and Distribution.
